IRMD
IRADIMED CORPORATION
Set alert
76.68 USD -9.06 -10.57%
76.35 Day range 82.28
76.42 52-week range 105.15
- YTD
- -21.18%
- 1 year
- +0.34%
- Open
- 82.28
- Prev close
- 85.74
- Mkt cap
- 980.51M
- Vol
- 218.00K
- Avg vol
- 123.88K
- EPS
- 1.79
- P/E
- 42.84
- Div yield
- 0.95%
More statistics
- Low
- 76.35
- High
- 82.28
- Forward P/E
- 34.95
- Beta
- 0.91
- Short ratio
- 5.23
- Inst. own
- 62.45%
- Dividend
- 0.80
- Ex-div date
- Aug 13, 2026
- Earnings
- Oct 30, 2026
- 50-d avg
- 85.89
- 200-d avg
- 92.73
- 1y target
- 118.00
Financial health
Altman Z-Score
43.50 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
6 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B3 / 5 overall
- DCF 3
- Return on Equity 5
- Return on Assets 5
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E 55.0×
FY 2016 5y median 36.2× FY 2025
P/S 14.8×
FY 2016 5y median 9.5× FY 2025
P/B 13.1×
FY 2016 5y median 8.0× FY 2025
P/FCF 72.0×
FY 2016 5y median 54.3× FY 2025
EV/EBITDA 40.2×
FY 2016 5y median 25.7× FY 2025
EV/Sales 14.2×
FY 2016 5y median 8.8× FY 2025
FCF Yield 1.4%
FY 2016 5y median 1.8% FY 2025
Profitability
Gross Margin 76.7%
FY 2016 5y median 76.7% FY 2025
Operating Margin 31.2%
FY 2016 5y median 30.0% FY 2025
Net Margin 26.8%
FY 2016 5y median 26.2% FY 2025
ROE 23.8%
FY 2016 5y median 22.2% FY 2025
ROIC 21.0%
FY 2016 5y median 19.3% FY 2025
ROA 20.7%
FY 2016 5y median 18.7% FY 2025
Growth (YoY)
Revenue 14.4%
FY 2016 FY 2025
Operating Income 19.0%
FY 2016 FY 2025
EPS (diluted) 16.7%
FY 2016 FY 2025
Free Cash Flow -2.5%
FY 2016 FY 2025
Financial Health
Current Ratio 8.0×
FY 2016 5y median 8.8× FY 2025
Quick Ratio 6.8×
FY 2016 5y median 7.6× FY 2025
Debt / Equity 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -1.7×
FY 2016 5y median -2.1× FY 2025
Interest Coverage 0.0×
FY 2016 5y median 0.0× FY 2025
Dividends
Dividend Yield 1.2%
FY 2016 5y median 2.0% FY 2025
Payout Ratio 66.9%
FY 2016 5y median 71.1% FY 2025
Annual · latest fiscal year ends 2025-12-31